Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives (2022)
- Authors:
- USP affiliated authors: MOREIRA, NATALIA CHERMONT DOS SANTOS - FMRP ; LIMA, JÉSSICA ELLEN BARBOSA DE FREITAS - FMRP ; CARVALHO, IVONE - FCFRP ; HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; MARCHIORI, MARCELO FIORI - FCFRP
- Unidades: FMRP; FCFRP; FFCLRP
- DOI: 10.3233/ADR-210061
- Subjects: DOENÇA DE ALZHEIMER; NEUROLOGIA
- Keywords: Acetylcholinesterase; Butyrylcholinesterase; Neurodegenerative diseases; Neuroprotection; PI3K/AKT pathway
- Language: Inglês
- Imprenta:
- Publisher place: Thousand Oaks
- Date published: 2022
- Source:
- Título: Journal of Alzheimer's Disease Reports
- ISSN: 2542-4823
- Volume/Número/Paginação/Ano: v. 6, n. 1, p. 177-193, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MOREIRA, Natália Chermont dos Santos et al. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives. Journal of Alzheimer's Disease Reports, v. 6, n. 1, p. 177-193, 2022Tradução . . Disponível em: https://doi.org/10.3233/ADR-210061. Acesso em: 26 jan. 2026. -
APA
Moreira, N. C. dos S., Lima, J. E. B. de F., Marchiori, M. F., Carvalho, I., & Sakamoto-Hojo, E. T. (2022). Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives. Journal of Alzheimer's Disease Reports, 6( 1), 177-193. doi:10.3233/ADR-210061 -
NLM
Moreira NC dos S, Lima JEB de F, Marchiori MF, Carvalho I, Sakamoto-Hojo ET. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives [Internet]. Journal of Alzheimer's Disease Reports. 2022 ; 6( 1): 177-193.[citado 2026 jan. 26 ] Available from: https://doi.org/10.3233/ADR-210061 -
Vancouver
Moreira NC dos S, Lima JEB de F, Marchiori MF, Carvalho I, Sakamoto-Hojo ET. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives [Internet]. Journal of Alzheimer's Disease Reports. 2022 ; 6( 1): 177-193.[citado 2026 jan. 26 ] Available from: https://doi.org/10.3233/ADR-210061 - Novel hybrid acetylcholinesterase inhibitors induce differentiation and neuritogenesis in neuronal cells in vitro through activation of the AKT pathway
- Mechanisms underlying the pathophysiology of type 2 diabetes: from risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia
- Oxidative stress, DNA damage, and transcriptional expression of DNA repair and stress response genes in diabetes mellitus
- Novel AChE and ROCK dual inhibitor designed for Alzheimer's disease therapy promotes neurodifferentiation and neuritogenesis in SHSY5Y cells
- Neuroprotective effect of acetylcholinesterase inhibitors in response to oxidative stress in neuronal SH-SY5Y cell line
- Brain organoids as a neuronal model applied in neuroscience and neurodegenerative diseases
- Acetylcholinesterase inhibitory activity, anti-inflammatory, and neuroprotective potential of Hippeastrum psittacinum (Ker Gawl.) herb (Amaryllidaceae)
- Novel dual AChE and ROCK2 inhibitor induces neurogenesis via PTEN/AKT pathway in Alzheimer’s disease model
- Insights into anti-trypanosomal agents based on synthetic glycoconjugates
- Estudo do potencial efeito neuroprotetor de inibidores de acetilcolinesterase em resposta ao estresse oxidativo induzido pelo peróxido de hidrogênio em linhagem neuronal SH-SY5Y
Informações sobre o DOI: 10.3233/ADR-210061 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003275559.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
